Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Porton Pharma Solutions is a leading global CDMO providing end-to-end R&D and GMP-compliant manufacturing services for small molecules, peptides ("tides"), biologics including monoclonal antibodies and antibody-drug conjugates, as well as advanced therapy medicinal products such as cell and gene therapies. The company serves over 1000 global clients with more than 3500 projects delivered by over 4200 employees across multiple sites worldwide. It does not develop its own proprietary drugs but enables pharmaceutical companies to bring their products from early development through commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Porton Pharma Solutions.